Evelyn Mantegani, Author at ASHG - Page 3 of 9

Evelyn Mantegani

New CRISPR Delivery Platform Reactivates Silenced Angelman Syndrome Gene Across the Brain

New CRISPR Delivery Platform Reactivates Silenced Angelman Syndrome Gene Across the Brain

For Immediate Release: Wednesday, October 21, 2026, 1:40 p.m. U.S. Eastern Time Media Contact: Evelyn Mantegani, +1 240-833-2014, [email protected] Presented By: Xiaona Lu, MD, PhD, Yale School of Medicine Gene editing could transform treatment for neurological genetic disorders, but delivering gene-editing tools broadly throughout the brain remains a major challenge. Researchers have developed a nonviral... Read More

Population Genomic Screening Advances Efforts to Detect Disease Risk Before Symptoms Begin and Improve Outcomes

Population Genomic Screening Advances Efforts to Detect Disease Risk Before Symptoms Begin and Improve Outcomes

For Immediate Release: Wednesday, October 21, 2026, 9:00 a.m. U.S. Eastern Time Media Contact: Evelyn Mantegani, +1 240-833-2014, [email protected] Rockville, Md. – DNA-based population health screening has been shown to support earlier detection and prevention of cancer, cardiovascular disease, and other conditions associated with identifiable genomic risks. A panel will discuss the development, implementation, and... Read More

Beyond a Single Autism Gene: Connecting Genetic Discovery, Clinical Testing, and Community Priorities

Beyond a Single Autism Gene: Connecting Genetic Discovery, Clinical Testing, and Community Priorities

For Immediate Release: Wednesday, October 21, 2026, 8:45 a.m. U.S. Eastern Time Media Contact: Evelyn Mantegani, +1 240-833-2014, [email protected] Rockville, Md. – Genetic discoveries are rapidly reshaping scientists’ understanding of autism, but translating those findings into meaningful benefits requires researchers to navigate autism’s extraordinary complexity and the variation of perspectives within the Autistic community. A... Read More

Population Genetic Screening Prompts Lasting Preventive Health Actions

Population Genetic Screening Prompts Lasting Preventive Health Actions

For Immediate Release: Tuesday, October 20, 2026, 5:00 p.m. U.S. Eastern Time Media Contact: Evelyn Mantegani, +1 240-833-2014, [email protected] Presented By: Catherine Hajek, MD, Helix Rockville, Md. – Familial hypercholesterolemia, hereditary breast and ovarian cancer, and Lynch syndrome affect an estimated 1% to 2% of the population. Although proven interventions can reduce associated health risks,... Read More